nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA1—esophageal cancer	0.445	0.569	CbGaD
Dorzolamide—CA2—esophageal cancer	0.337	0.431	CbGaD
Dorzolamide—Brinzolamide—CA1—esophageal cancer	0.00411	0.569	CrCbGaD
Dorzolamide—CA6—exocrine gland—esophageal cancer	0.00392	0.174	CbGeAlD
Dorzolamide—Brinzolamide—CA2—esophageal cancer	0.00311	0.431	CrCbGaD
Dorzolamide—Memory loss—Cisplatin—esophageal cancer	0.00186	0.0416	CcSEcCtD
Dorzolamide—Punctate keratitis—Capecitabine—esophageal cancer	0.0016	0.0357	CcSEcCtD
Dorzolamide—CA7—trachea—esophageal cancer	0.00156	0.0691	CbGeAlD
Dorzolamide—CA2—exocrine gland—esophageal cancer	0.00135	0.0599	CbGeAlD
Dorzolamide—CA7—digestive system—esophageal cancer	0.00134	0.0595	CbGeAlD
Dorzolamide—Scab—Capecitabine—esophageal cancer	0.00127	0.0283	CcSEcCtD
Dorzolamide—CA9—digestive system—esophageal cancer	0.00118	0.0522	CbGeAlD
Dorzolamide—Arterial thrombosis—Methotrexate—esophageal cancer	0.00111	0.0249	CcSEcCtD
Dorzolamide—CA4—neck—esophageal cancer	0.00104	0.0462	CbGeAlD
Dorzolamide—CA12—trachea—esophageal cancer	0.00101	0.0449	CbGeAlD
Dorzolamide—Rales—Capecitabine—esophageal cancer	0.000983	0.022	CcSEcCtD
Dorzolamide—CA12—digestive system—esophageal cancer	0.00087	0.0386	CbGeAlD
Dorzolamide—CA2—neck—esophageal cancer	0.000863	0.0383	CbGeAlD
Dorzolamide—Peripheral coldness—Capecitabine—esophageal cancer	0.000847	0.0189	CcSEcCtD
Dorzolamide—Rales—Methotrexate—esophageal cancer	0.000732	0.0164	CcSEcCtD
Dorzolamide—CA12—lung—esophageal cancer	0.000726	0.0323	CbGeAlD
Dorzolamide—CA1—digestive system—esophageal cancer	0.000689	0.0306	CbGeAlD
Dorzolamide—CA5B—lung—esophageal cancer	0.000652	0.0289	CbGeAlD
Dorzolamide—Respiratory distress—Capecitabine—esophageal cancer	0.000635	0.0142	CcSEcCtD
Dorzolamide—CA4—trachea—esophageal cancer	0.000626	0.0278	CbGeAlD
Dorzolamide—Keratitis—Capecitabine—esophageal cancer	0.000622	0.0139	CcSEcCtD
Dorzolamide—CA2—epithelium—esophageal cancer	0.000587	0.0261	CbGeAlD
Dorzolamide—CA2—bronchus—esophageal cancer	0.000578	0.0257	CbGeAlD
Dorzolamide—CA1—lung—esophageal cancer	0.000575	0.0256	CbGeAlD
Dorzolamide—Hepatomegaly—Capecitabine—esophageal cancer	0.00057	0.0127	CcSEcCtD
Dorzolamide—Pain—Carboplatin—esophageal cancer	0.000569	0.0127	CcSEcCtD
Dorzolamide—CA2—smooth muscle tissue—esophageal cancer	0.000566	0.0251	CbGeAlD
Dorzolamide—Throat sore—Capecitabine—esophageal cancer	0.000559	0.0125	CcSEcCtD
Dorzolamide—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000554	0.0124	CcSEcCtD
Dorzolamide—CA4—digestive system—esophageal cancer	0.000539	0.0239	CbGeAlD
Dorzolamide—Rash erythematous—Capecitabine—esophageal cancer	0.000527	0.0118	CcSEcCtD
Dorzolamide—Body temperature increased—Carboplatin—esophageal cancer	0.000526	0.0118	CcSEcCtD
Dorzolamide—CA2—trachea—esophageal cancer	0.000519	0.0231	CbGeAlD
Dorzolamide—Psoriasis—Methotrexate—esophageal cancer	0.000478	0.0107	CcSEcCtD
Dorzolamide—Eye irritation—Capecitabine—esophageal cancer	0.000472	0.0106	CcSEcCtD
Dorzolamide—CA4—lung—esophageal cancer	0.00045	0.02	CbGeAlD
Dorzolamide—CA2—digestive system—esophageal cancer	0.000447	0.0198	CbGeAlD
Dorzolamide—CA5B—lymph node—esophageal cancer	0.000446	0.0198	CbGeAlD
Dorzolamide—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000443	0.00991	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000438	0.00979	CcSEcCtD
Dorzolamide—Lacrimation increased—Capecitabine—esophageal cancer	0.000438	0.00978	CcSEcCtD
Dorzolamide—Nasal congestion—Cisplatin—esophageal cancer	0.000436	0.00974	CcSEcCtD
Dorzolamide—Amnesia—Cisplatin—esophageal cancer	0.000423	0.00945	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000405	0.00906	CcSEcCtD
Dorzolamide—CA1—lymph node—esophageal cancer	0.000394	0.0175	CbGeAlD
Dorzolamide—CYP2C9—digestive system—esophageal cancer	0.000378	0.0168	CbGeAlD
Dorzolamide—CA2—lung—esophageal cancer	0.000373	0.0166	CbGeAlD
Dorzolamide—Dry eye—Capecitabine—esophageal cancer	0.000372	0.00833	CcSEcCtD
Dorzolamide—Eye pain—Capecitabine—esophageal cancer	0.000324	0.00725	CcSEcCtD
Dorzolamide—Libido decreased—Capecitabine—esophageal cancer	0.000316	0.00706	CcSEcCtD
Dorzolamide—Amnesia—Capecitabine—esophageal cancer	0.000312	0.00696	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00031	0.00693	CcSEcCtD
Dorzolamide—CA4—lymph node—esophageal cancer	0.000308	0.0137	CbGeAlD
Dorzolamide—Respiratory failure—Methotrexate—esophageal cancer	0.000306	0.00683	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000302	0.00674	CcSEcCtD
Dorzolamide—Myocardial infarction—Cisplatin—esophageal cancer	0.0003	0.00671	CcSEcCtD
Dorzolamide—Cardiac failure—Capecitabine—esophageal cancer	0.0003	0.0067	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000299	0.00668	CcSEcCtD
Dorzolamide—Conjunctivitis—Cisplatin—esophageal cancer	0.000297	0.00665	CcSEcCtD
Dorzolamide—Diplopia—Capecitabine—esophageal cancer	0.000293	0.00654	CcSEcCtD
Dorzolamide—Pain in extremity—Capecitabine—esophageal cancer	0.000293	0.00654	CcSEcCtD
Dorzolamide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00029	0.00649	CcSEcCtD
Dorzolamide—CYP3A4—digestive system—esophageal cancer	0.000288	0.0128	CbGeAlD
Dorzolamide—Bradycardia—Cisplatin—esophageal cancer	0.00028	0.00625	CcSEcCtD
Dorzolamide—Cardiac arrest—Capecitabine—esophageal cancer	0.000278	0.00622	CcSEcCtD
Dorzolamide—Mood swings—Capecitabine—esophageal cancer	0.000277	0.0062	CcSEcCtD
Dorzolamide—Pulmonary oedema—Methotrexate—esophageal cancer	0.000267	0.00597	CcSEcCtD
Dorzolamide—Visual impairment—Cisplatin—esophageal cancer	0.000265	0.00592	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000264	0.00589	CcSEcCtD
Dorzolamide—Tinnitus—Cisplatin—esophageal cancer	0.000256	0.00573	CcSEcCtD
Dorzolamide—CA2—lymph node—esophageal cancer	0.000255	0.0113	CbGeAlD
Dorzolamide—Influenza—Capecitabine—esophageal cancer	0.000253	0.00566	CcSEcCtD
Dorzolamide—Bronchospasm—Capecitabine—esophageal cancer	0.000249	0.00556	CcSEcCtD
Dorzolamide—Angina pectoris—Capecitabine—esophageal cancer	0.000246	0.00551	CcSEcCtD
Dorzolamide—Arrhythmia—Cisplatin—esophageal cancer	0.000245	0.00549	CcSEcCtD
Dorzolamide—Bronchitis—Capecitabine—esophageal cancer	0.000243	0.00544	CcSEcCtD
Dorzolamide—Alopecia—Cisplatin—esophageal cancer	0.000243	0.00543	CcSEcCtD
Dorzolamide—Erythema—Cisplatin—esophageal cancer	0.000239	0.00535	CcSEcCtD
Dorzolamide—Dysuria—Capecitabine—esophageal cancer	0.000237	0.00529	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000235	0.00526	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000231	0.00516	CcSEcCtD
Dorzolamide—Visual disturbance—Methotrexate—esophageal cancer	0.00023	0.00514	CcSEcCtD
Dorzolamide—Weight decreased—Capecitabine—esophageal cancer	0.000229	0.00512	CcSEcCtD
Dorzolamide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000228	0.0051	CcSEcCtD
Dorzolamide—Vision blurred—Cisplatin—esophageal cancer	0.000225	0.00504	CcSEcCtD
Dorzolamide—Depression—Capecitabine—esophageal cancer	0.000225	0.00503	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000224	0.005	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000222	0.00497	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000222	0.00497	CcSEcCtD
Dorzolamide—Myocardial infarction—Capecitabine—esophageal cancer	0.000221	0.00494	CcSEcCtD
Dorzolamide—Conjunctivitis—Capecitabine—esophageal cancer	0.000219	0.0049	CcSEcCtD
Dorzolamide—Urinary tract infection—Capecitabine—esophageal cancer	0.000219	0.0049	CcSEcCtD
Dorzolamide—Epistaxis—Capecitabine—esophageal cancer	0.000213	0.00476	CcSEcCtD
Dorzolamide—Agranulocytosis—Capecitabine—esophageal cancer	0.00021	0.00471	CcSEcCtD
Dorzolamide—Mood swings—Methotrexate—esophageal cancer	0.000206	0.00461	CcSEcCtD
Dorzolamide—Bradycardia—Capecitabine—esophageal cancer	0.000206	0.00461	CcSEcCtD
Dorzolamide—Anxiety—Cisplatin—esophageal cancer	0.000203	0.00454	CcSEcCtD
Dorzolamide—Discomfort—Cisplatin—esophageal cancer	0.000201	0.0045	CcSEcCtD
Dorzolamide—Pharyngitis—Capecitabine—esophageal cancer	0.000201	0.00449	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000196	0.00439	CcSEcCtD
Dorzolamide—Oedema—Cisplatin—esophageal cancer	0.000195	0.00436	CcSEcCtD
Dorzolamide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000195	0.00436	CcSEcCtD
Dorzolamide—Visual impairment—Capecitabine—esophageal cancer	0.000195	0.00436	CcSEcCtD
Dorzolamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000191	0.00428	CcSEcCtD
Dorzolamide—Tinnitus—Capecitabine—esophageal cancer	0.000189	0.00422	CcSEcCtD
Dorzolamide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000189	0.00422	CcSEcCtD
Dorzolamide—Anorexia—Cisplatin—esophageal cancer	0.000186	0.00416	CcSEcCtD
Dorzolamide—Hypotension—Cisplatin—esophageal cancer	0.000182	0.00408	CcSEcCtD
Dorzolamide—Arrhythmia—Capecitabine—esophageal cancer	0.000181	0.00404	CcSEcCtD
Dorzolamide—Alopecia—Capecitabine—esophageal cancer	0.000179	0.004	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000178	0.00397	CcSEcCtD
Dorzolamide—Erythema—Capecitabine—esophageal cancer	0.000176	0.00394	CcSEcCtD
Dorzolamide—Dysuria—Methotrexate—esophageal cancer	0.000176	0.00394	CcSEcCtD
Dorzolamide—Paraesthesia—Cisplatin—esophageal cancer	0.000175	0.00392	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000175	0.00391	CcSEcCtD
Dorzolamide—Dyspnoea—Cisplatin—esophageal cancer	0.000174	0.00389	CcSEcCtD
Dorzolamide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000173	0.00388	CcSEcCtD
Dorzolamide—Dysgeusia—Capecitabine—esophageal cancer	0.000173	0.00386	CcSEcCtD
Dorzolamide—Back pain—Capecitabine—esophageal cancer	0.00017	0.00381	CcSEcCtD
Dorzolamide—Decreased appetite—Cisplatin—esophageal cancer	0.00017	0.00379	CcSEcCtD
Dorzolamide—Depression—Methotrexate—esophageal cancer	0.000167	0.00374	CcSEcCtD
Dorzolamide—Pain—Cisplatin—esophageal cancer	0.000167	0.00373	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000166	0.00372	CcSEcCtD
Dorzolamide—Vision blurred—Capecitabine—esophageal cancer	0.000166	0.00371	CcSEcCtD
Dorzolamide—Conjunctivitis—Methotrexate—esophageal cancer	0.000163	0.00365	CcSEcCtD
Dorzolamide—Sweating—Methotrexate—esophageal cancer	0.000161	0.0036	CcSEcCtD
Dorzolamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000161	0.0036	CcSEcCtD
Dorzolamide—Epistaxis—Methotrexate—esophageal cancer	0.000158	0.00354	CcSEcCtD
Dorzolamide—Vertigo—Capecitabine—esophageal cancer	0.000158	0.00354	CcSEcCtD
Dorzolamide—Syncope—Capecitabine—esophageal cancer	0.000158	0.00353	CcSEcCtD
Dorzolamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000157	0.0035	CcSEcCtD
Dorzolamide—Palpitations—Capecitabine—esophageal cancer	0.000156	0.00348	CcSEcCtD
Dorzolamide—Loss of consciousness—Capecitabine—esophageal cancer	0.000155	0.00346	CcSEcCtD
Dorzolamide—Body temperature increased—Cisplatin—esophageal cancer	0.000154	0.00345	CcSEcCtD
Dorzolamide—Cough—Capecitabine—esophageal cancer	0.000154	0.00344	CcSEcCtD
Dorzolamide—Hypertension—Capecitabine—esophageal cancer	0.000152	0.0034	CcSEcCtD
Dorzolamide—Chest pain—Capecitabine—esophageal cancer	0.00015	0.00335	CcSEcCtD
Dorzolamide—Arthralgia—Capecitabine—esophageal cancer	0.00015	0.00335	CcSEcCtD
Dorzolamide—Pharyngitis—Methotrexate—esophageal cancer	0.00015	0.00334	CcSEcCtD
Dorzolamide—Anxiety—Capecitabine—esophageal cancer	0.00015	0.00334	CcSEcCtD
Dorzolamide—Discomfort—Capecitabine—esophageal cancer	0.000148	0.00331	CcSEcCtD
Dorzolamide—Dry mouth—Capecitabine—esophageal cancer	0.000147	0.00328	CcSEcCtD
Dorzolamide—Visual impairment—Methotrexate—esophageal cancer	0.000145	0.00325	CcSEcCtD
Dorzolamide—Confusional state—Capecitabine—esophageal cancer	0.000145	0.00324	CcSEcCtD
Dorzolamide—Oedema—Capecitabine—esophageal cancer	0.000144	0.00322	CcSEcCtD
Dorzolamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000144	0.00321	CcSEcCtD
Dorzolamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000143	0.00319	CcSEcCtD
Dorzolamide—Shock—Capecitabine—esophageal cancer	0.000142	0.00316	CcSEcCtD
Dorzolamide—Tinnitus—Methotrexate—esophageal cancer	0.000141	0.00314	CcSEcCtD
Dorzolamide—Asthenia—Cisplatin—esophageal cancer	0.00014	0.00313	CcSEcCtD
Dorzolamide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000139	0.00311	CcSEcCtD
Dorzolamide—Anorexia—Capecitabine—esophageal cancer	0.000137	0.00307	CcSEcCtD
Dorzolamide—Hypotension—Capecitabine—esophageal cancer	0.000134	0.00301	CcSEcCtD
Dorzolamide—Diarrhoea—Cisplatin—esophageal cancer	0.000134	0.00299	CcSEcCtD
Dorzolamide—Alopecia—Methotrexate—esophageal cancer	0.000133	0.00298	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—esophageal cancer	0.000131	0.00293	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000131	0.00293	CcSEcCtD
Dorzolamide—Insomnia—Capecitabine—esophageal cancer	0.00013	0.00291	CcSEcCtD
Dorzolamide—Paraesthesia—Capecitabine—esophageal cancer	0.000129	0.00289	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—esophageal cancer	0.000128	0.00287	CcSEcCtD
Dorzolamide—Dyspnoea—Capecitabine—esophageal cancer	0.000128	0.00287	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—esophageal cancer	0.000127	0.00284	CcSEcCtD
Dorzolamide—Dyspepsia—Capecitabine—esophageal cancer	0.000127	0.00283	CcSEcCtD
Dorzolamide—Decreased appetite—Capecitabine—esophageal cancer	0.000125	0.0028	CcSEcCtD
Dorzolamide—Vomiting—Cisplatin—esophageal cancer	0.000124	0.00277	CcSEcCtD
Dorzolamide—Fatigue—Capecitabine—esophageal cancer	0.000124	0.00277	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—esophageal cancer	0.000124	0.00276	CcSEcCtD
Dorzolamide—Rash—Cisplatin—esophageal cancer	0.000123	0.00275	CcSEcCtD
Dorzolamide—Pain—Capecitabine—esophageal cancer	0.000123	0.00275	CcSEcCtD
Dorzolamide—Dermatitis—Cisplatin—esophageal cancer	0.000123	0.00275	CcSEcCtD
Dorzolamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000119	0.00265	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—esophageal cancer	0.000118	0.00264	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000118	0.00263	CcSEcCtD
Dorzolamide—Nausea—Cisplatin—esophageal cancer	0.000116	0.00259	CcSEcCtD
Dorzolamide—Cough—Methotrexate—esophageal cancer	0.000115	0.00256	CcSEcCtD
Dorzolamide—Urticaria—Capecitabine—esophageal cancer	0.000114	0.00255	CcSEcCtD
Dorzolamide—Body temperature increased—Capecitabine—esophageal cancer	0.000114	0.00254	CcSEcCtD
Dorzolamide—Abdominal pain—Capecitabine—esophageal cancer	0.000114	0.00254	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—esophageal cancer	0.000112	0.0025	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—esophageal cancer	0.000112	0.0025	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—esophageal cancer	0.00011	0.00247	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—esophageal cancer	0.000108	0.00241	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000107	0.00239	CcSEcCtD
Dorzolamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000106	0.00237	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000104	0.00231	CcSEcCtD
Dorzolamide—Asthenia—Capecitabine—esophageal cancer	0.000103	0.00231	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—esophageal cancer	0.000102	0.00228	CcSEcCtD
Dorzolamide—Pruritus—Capecitabine—esophageal cancer	0.000102	0.00228	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—esophageal cancer	0.0001	0.00224	CcSEcCtD
Dorzolamide—Diarrhoea—Capecitabine—esophageal cancer	9.84e-05	0.0022	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.76e-05	0.00218	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—esophageal cancer	9.69e-05	0.00217	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—esophageal cancer	9.62e-05	0.00215	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—esophageal cancer	9.55e-05	0.00213	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—esophageal cancer	9.52e-05	0.00213	CcSEcCtD
Dorzolamide—Dizziness—Capecitabine—esophageal cancer	9.51e-05	0.00213	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—esophageal cancer	9.43e-05	0.00211	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—esophageal cancer	9.31e-05	0.00208	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—esophageal cancer	9.23e-05	0.00206	CcSEcCtD
Dorzolamide—Pain—Methotrexate—esophageal cancer	9.16e-05	0.00205	CcSEcCtD
Dorzolamide—Vomiting—Capecitabine—esophageal cancer	9.15e-05	0.00204	CcSEcCtD
Dorzolamide—Rash—Capecitabine—esophageal cancer	9.07e-05	0.00203	CcSEcCtD
Dorzolamide—Dermatitis—Capecitabine—esophageal cancer	9.06e-05	0.00203	CcSEcCtD
Dorzolamide—Headache—Capecitabine—esophageal cancer	9.01e-05	0.00201	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—esophageal cancer	8.82e-05	0.00197	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—esophageal cancer	8.76e-05	0.00196	CcSEcCtD
Dorzolamide—Nausea—Capecitabine—esophageal cancer	8.54e-05	0.00191	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—esophageal cancer	8.51e-05	0.0019	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—esophageal cancer	8.47e-05	0.00189	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—esophageal cancer	8.47e-05	0.00189	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—esophageal cancer	7.89e-05	0.00176	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—esophageal cancer	7.68e-05	0.00172	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—esophageal cancer	7.58e-05	0.00169	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—esophageal cancer	7.33e-05	0.00164	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—esophageal cancer	7.08e-05	0.00158	CcSEcCtD
Dorzolamide—Vomiting—Methotrexate—esophageal cancer	6.81e-05	0.00152	CcSEcCtD
Dorzolamide—Rash—Methotrexate—esophageal cancer	6.75e-05	0.00151	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—esophageal cancer	6.75e-05	0.00151	CcSEcCtD
Dorzolamide—Headache—Methotrexate—esophageal cancer	6.71e-05	0.0015	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—esophageal cancer	6.36e-05	0.00142	CcSEcCtD
Dorzolamide—CA2—Metabolism—TPI1—esophageal cancer	5.03e-05	0.000349	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTO1—esophageal cancer	5.03e-05	0.000349	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALDOB—esophageal cancer	5.03e-05	0.000349	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	4.9e-05	0.00034	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ADH1B—esophageal cancer	4.9e-05	0.00034	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	4.85e-05	0.000337	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	4.85e-05	0.000336	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GAPDH—esophageal cancer	4.84e-05	0.000336	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	4.82e-05	0.000335	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—TPI1—esophageal cancer	4.82e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTO1—esophageal cancer	4.82e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALDOB—esophageal cancer	4.82e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1B1—esophageal cancer	4.82e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CRABP1—esophageal cancer	4.79e-05	0.000333	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ENO1—esophageal cancer	4.78e-05	0.000331	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS1—esophageal cancer	4.78e-05	0.000331	CbGpPWpGaD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	4.73e-05	0.000328	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PSME2—esophageal cancer	4.71e-05	0.000327	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PSME1—esophageal cancer	4.71e-05	0.000327	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1B1—esophageal cancer	4.7e-05	0.000326	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1B1—esophageal cancer	4.7e-05	0.000326	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—TYMP—esophageal cancer	4.68e-05	0.000325	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GAPDH—esophageal cancer	4.64e-05	0.000322	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALDOB—esophageal cancer	4.62e-05	0.000321	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CRABP1—esophageal cancer	4.6e-05	0.000319	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	4.59e-05	0.000319	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GNG7—esophageal cancer	4.56e-05	0.000316	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	4.56e-05	0.000316	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP26A1—esophageal cancer	4.56e-05	0.000316	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP19A1—esophageal cancer	4.53e-05	0.000314	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	4.49e-05	0.000311	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GAPDH—esophageal cancer	4.45e-05	0.000309	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALOX15—esophageal cancer	4.44e-05	0.000308	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	4.42e-05	0.000307	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP19A1—esophageal cancer	4.42e-05	0.000306	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP19A1—esophageal cancer	4.42e-05	0.000306	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CRABP1—esophageal cancer	4.41e-05	0.000306	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP1B1—esophageal cancer	4.38e-05	0.000304	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1B1—esophageal cancer	4.38e-05	0.000304	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GNG7—esophageal cancer	4.37e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	4.28e-05	0.000297	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALDH2—esophageal cancer	4.27e-05	0.000297	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTO1—esophageal cancer	4.24e-05	0.000294	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—TPI1—esophageal cancer	4.24e-05	0.000294	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GNG7—esophageal cancer	4.19e-05	0.000291	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	4.17e-05	0.000289	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—HMOX1—esophageal cancer	4.13e-05	0.000287	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP19A1—esophageal cancer	4.12e-05	0.000286	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP19A1—esophageal cancer	4.12e-05	0.000286	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	4.11e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALDH2—esophageal cancer	4.1e-05	0.000284	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—EP300—esophageal cancer	4.07e-05	0.000283	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTT1—esophageal cancer	4.06e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALDOB—esophageal cancer	4.06e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1B1—esophageal cancer	4.06e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—HMOX1—esophageal cancer	4.03e-05	0.00028	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—HMOX1—esophageal cancer	4.03e-05	0.00028	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP2A6—esophageal cancer	4.02e-05	0.000279	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ABCB1—esophageal cancer	3.97e-05	0.000275	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALDH2—esophageal cancer	3.93e-05	0.000273	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GAPDH—esophageal cancer	3.91e-05	0.000271	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	3.91e-05	0.000271	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTT1—esophageal cancer	3.9e-05	0.00027	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CRABP1—esophageal cancer	3.87e-05	0.000269	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ABCB1—esophageal cancer	3.87e-05	0.000268	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ABCB1—esophageal cancer	3.87e-05	0.000268	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	3.85e-05	0.000267	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP2A6—esophageal cancer	3.85e-05	0.000267	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP19A1—esophageal cancer	3.82e-05	0.000265	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ENO1—esophageal cancer	3.81e-05	0.000264	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS1—esophageal cancer	3.81e-05	0.000264	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	3.77e-05	0.000261	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—HMOX1—esophageal cancer	3.76e-05	0.000261	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—HMOX1—esophageal cancer	3.76e-05	0.000261	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSME2—esophageal cancer	3.75e-05	0.00026	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSME1—esophageal cancer	3.75e-05	0.00026	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTT1—esophageal cancer	3.74e-05	0.000259	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP2A6—esophageal cancer	3.69e-05	0.000256	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GNG7—esophageal cancer	3.69e-05	0.000256	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	3.67e-05	0.000255	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS1—esophageal cancer	3.65e-05	0.000253	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ENO1—esophageal cancer	3.65e-05	0.000253	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	3.62e-05	0.000251	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ABCB1—esophageal cancer	3.61e-05	0.00025	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ABCB1—esophageal cancer	3.61e-05	0.00025	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSME1—esophageal cancer	3.6e-05	0.00025	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSME2—esophageal cancer	3.6e-05	0.00025	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ENO1—esophageal cancer	3.5e-05	0.000243	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS1—esophageal cancer	3.5e-05	0.000243	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—HMOX1—esophageal cancer	3.48e-05	0.000242	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALDH2—esophageal cancer	3.45e-05	0.00024	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSME2—esophageal cancer	3.45e-05	0.000239	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSME1—esophageal cancer	3.45e-05	0.000239	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	3.4e-05	0.000236	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ABCB1—esophageal cancer	3.34e-05	0.000232	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTT1—esophageal cancer	3.28e-05	0.000228	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP2A6—esophageal cancer	3.25e-05	0.000225	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1B1—esophageal cancer	3.24e-05	0.000225	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	3.23e-05	0.000224	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	3.2e-05	0.000222	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1B1—esophageal cancer	3.11e-05	0.000215	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ENO1—esophageal cancer	3.08e-05	0.000214	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS1—esophageal cancer	3.08e-05	0.000214	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP19A1—esophageal cancer	3.05e-05	0.000211	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSME2—esophageal cancer	3.03e-05	0.00021	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSME1—esophageal cancer	3.03e-05	0.00021	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	3.03e-05	0.00021	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1B1—esophageal cancer	2.98e-05	0.000207	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP19A1—esophageal cancer	2.92e-05	0.000203	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—esophageal cancer	2.91e-05	0.000202	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP19A1—esophageal cancer	2.8e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—HMOX1—esophageal cancer	2.78e-05	0.000193	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ABCB1—esophageal cancer	2.67e-05	0.000185	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—HMOX1—esophageal cancer	2.66e-05	0.000185	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CREBBP—esophageal cancer	2.65e-05	0.000184	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1B1—esophageal cancer	2.62e-05	0.000182	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CREBBP—esophageal cancer	2.58e-05	0.000179	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CREBBP—esophageal cancer	2.58e-05	0.000179	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.58e-05	0.000179	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCB1—esophageal cancer	2.56e-05	0.000177	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HMOX1—esophageal cancer	2.55e-05	0.000177	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.55e-05	0.000177	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.54e-05	0.000176	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP19A1—esophageal cancer	2.46e-05	0.000171	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCB1—esophageal cancer	2.45e-05	0.00017	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.42e-05	0.000168	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CREBBP—esophageal cancer	2.41e-05	0.000167	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CREBBP—esophageal cancer	2.41e-05	0.000167	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.39e-05	0.000166	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NOS3—esophageal cancer	2.37e-05	0.000165	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NOS3—esophageal cancer	2.31e-05	0.000161	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NOS3—esophageal cancer	2.31e-05	0.000161	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HMOX1—esophageal cancer	2.25e-05	0.000156	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CREBBP—esophageal cancer	2.24e-05	0.000155	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.22e-05	0.000154	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—esophageal cancer	2.17e-05	0.000151	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NOS3—esophageal cancer	2.16e-05	0.00015	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NOS3—esophageal cancer	2.16e-05	0.00015	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCB1—esophageal cancer	2.16e-05	0.00015	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—esophageal cancer	2.12e-05	0.000147	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—esophageal cancer	2.12e-05	0.000147	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NOS3—esophageal cancer	2e-05	0.000139	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—esophageal cancer	1.98e-05	0.000137	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—esophageal cancer	1.98e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.97e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.97e-05	0.000137	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—esophageal cancer	1.83e-05	0.000127	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—EP300—esophageal cancer	1.81e-05	0.000125	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CREBBP—esophageal cancer	1.78e-05	0.000124	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.76e-05	0.000122	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—EP300—esophageal cancer	1.76e-05	0.000122	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—EP300—esophageal cancer	1.76e-05	0.000122	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CREBBP—esophageal cancer	1.71e-05	0.000119	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.68e-05	0.000116	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA1—esophageal cancer	1.68e-05	0.000116	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—EP300—esophageal cancer	1.64e-05	0.000114	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—EP300—esophageal cancer	1.64e-05	0.000114	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CREBBP—esophageal cancer	1.64e-05	0.000114	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—esophageal cancer	1.6e-05	0.000111	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA2—esophageal cancer	1.53e-05	0.000106	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—esophageal cancer	1.53e-05	0.000106	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—EP300—esophageal cancer	1.52e-05	0.000106	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.5e-05	0.000104	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—esophageal cancer	1.47e-05	0.000102	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—esophageal cancer	1.46e-05	0.000101	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CREBBP—esophageal cancer	1.44e-05	9.99e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.43e-05	9.9e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADH7—esophageal cancer	1.43e-05	9.9e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.41e-05	9.79e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—esophageal cancer	1.4e-05	9.71e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—esophageal cancer	1.34e-05	9.31e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—esophageal cancer	1.34e-05	9.27e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—esophageal cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—esophageal cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—esophageal cancer	1.29e-05	8.95e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.25e-05	8.68e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—esophageal cancer	1.22e-05	8.43e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—esophageal cancer	1.22e-05	8.43e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—EP300—esophageal cancer	1.21e-05	8.42e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TYMP—esophageal cancer	1.2e-05	8.3e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—esophageal cancer	1.18e-05	8.18e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—EP300—esophageal cancer	1.16e-05	8.08e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.16e-05	8.07e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.13e-05	7.86e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—esophageal cancer	1.13e-05	7.81e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—EP300—esophageal cancer	1.12e-05	7.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.11e-05	7.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.11e-05	7.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.08e-05	7.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TPI1—esophageal cancer	1.08e-05	7.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.04e-05	7.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA2—esophageal cancer	1.01e-05	7.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.98e-06	6.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.89e-06	6.86e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—EP300—esophageal cancer	9.81e-06	6.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADH7—esophageal cancer	9.41e-06	6.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.41e-06	6.53e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GNG7—esophageal cancer	9.41e-06	6.53e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—esophageal cancer	8.98e-06	6.23e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.82e-06	6.12e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—esophageal cancer	8.61e-06	5.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.38e-06	5.82e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	8.29e-06	5.75e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.26e-06	5.73e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—esophageal cancer	8.25e-06	5.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.25e-06	5.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TYMP—esophageal cancer	7.89e-06	5.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ENO1—esophageal cancer	7.86e-06	5.45e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.86e-06	5.45e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSME2—esophageal cancer	7.74e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSME1—esophageal cancer	7.74e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.67e-06	5.32e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.48e-06	5.19e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—esophageal cancer	7.26e-06	5.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TPI1—esophageal cancer	7.13e-06	4.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.13e-06	4.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.84e-06	4.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.76e-06	4.69e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.68e-06	4.64e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.58e-06	4.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.52e-06	4.53e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.28e-06	4.36e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GNG7—esophageal cancer	6.2e-06	4.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.81e-06	4.03e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.73e-06	3.98e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.62e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.53e-06	3.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.5e-06	3.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.47e-06	3.79e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ENO1—esophageal cancer	5.18e-06	3.6e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.18e-06	3.6e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSME1—esophageal cancer	5.11e-06	3.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSME2—esophageal cancer	5.11e-06	3.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.41e-06	3.06e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.16e-06	2.89e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.14e-06	2.87e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.78e-06	2.62e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.68e-06	2.55e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.63e-06	2.52e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—esophageal cancer	3.29e-06	2.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.01e-06	2.09e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—EP300—esophageal cancer	2.5e-06	1.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.42e-06	1.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—esophageal cancer	2.17e-06	1.51e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.99e-06	1.38e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.85e-06	1.29e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—EP300—esophageal cancer	1.65e-06	1.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.22e-06	8.48e-06	CbGpPWpGaD
